Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Materialise is a global leader in 3D printing solutions with over three decades of experience. In healthcare, it provides clinically accepted R&D software and hardware for personalized engineering, analysis, simulation tools, patient-specific implants, and surgical guides. The company is running clinical trials on bioresorbable 3D printed implants for pediatric patients at University of Michigan Health as of early 2025[6][10]. Its products are widely used by hospitals worldwide to improve patient outcomes through personalized care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Materialise.